Project description DEENESFRITPL Novel diagnostic platform for COVID-19 rapid test The EU-funded DECISION project is developing a new class of COVID-19 diagnostic platforms and tests in a joint effort by teams from Italy, Spain and Germany. The diagnostic platform will enable the rapid detection of COVID-19 infections on-site in any possible setting, including drive-through testing centres, airports or medical offices. The low-cost, miniature, disposable diagnostic platform is powered by a next-generation nucleic acid amplification technology called pulse controlled amplification (PCA®), providing sample-to-answer workflows in less than 15 minutes. The objective is to deliver the molecular diagnostic platform and coronavirus test within five months after the start of the project. Show the project objective Hide the project objective Objective The DECISION consortium is developing a new class of diagnostic platform that will transform the fight against pandemics. The low-cost, miniaturised, disposable molecular diagnostic platform will allow for patient testing virtually anywhere, within a few minutes, with laboratory quality performance. The diagnostic platform will enable rapid detection of Covid-19 infections on-site in a multitude of settings including drive-through testing centres, physician offices, airports, hospitals and quarantine centres. First demonstrators of the disposable molecular diagnostic platform and coronavirus test will be available five months after the start of the project and could be provided to emergency first responders and public health authorities. The platform is powered by a next-generation nucleic acid amplification technology called Pulse Controlled Amplification (PCA®), which enables sample-to-answer workflows in 15 minutes or less. The DECISION consortium is comprised of teams from Italy, Spain and Germany, and is highly motivated to develop a ground-breaking diagnostic solution to help the serious crisis faced across the world due to the Covid-19 epidemic. Fields of science medical and health scienceshealth sciencespublic healthepidemiologypandemicsmedical and health scienceshealth sciencesinfectious diseasesRNA virusescoronaviruses Keywords molecular platform onsite POC point of care ultrafast PCR first responder home test rapid detection molecular testing handheld portable battery powered Programme(s) H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme H2020-EU.3.1.7. - Innovative Medicines Initiative 2 (IMI2) Topic(s) IMI2-2020-21-01 - Development of therapeutics and diagnostics combatting coronavirus infections Call for proposal H2020-JTI-IMI2-2020-21-single-stage See other projects for this call Funding Scheme RIA - Research and Innovation action Coordinator AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH Net EU contribution € 2 064 178,49 Address Giefinggasse 4 1210 Wien Austria See on map Region Ostösterreich Wien Wien Activity type Research Organisations Links Contact the organisation Opens in new window Website Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 0,00 Participants (4) Sort alphabetically Sort by Net EU contribution Expand all Collapse all MICROLIQUID SL Participation ended Spain Net EU contribution € 343 053,24 Address Avenida uribarri 19-1 saiolan 20500 Arrasate mondragon See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Noreste País Vasco Gipuzkoa Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Website Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 0,00 ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO Italy Net EU contribution € 406 350,00 Address Via portuense, 292 00149 Roma See on map Region Centro (IT) Lazio Roma Activity type Research Organisations Links Contact the organisation Opens in new window Website Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 0,00 BUNDESMINISTERIUM DER VERTEIDIGUNG Germany Net EU contribution € 425 250,00 Address Fontainengraben 150 53123 Bonn See on map Region Nordrhein-Westfalen Köln Bonn, Kreisfreie Stadt Activity type Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments) Links Contact the organisation Opens in new window Website Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 0,00 GNA BIOSOLUTIONS GMBH Germany Net EU contribution € 196 268,27 Address Am klopferspitz 19 82152 Martinsried See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Bayern Oberbayern München, Landkreis Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 312 500,00
